Patents Assigned to LASCCO SA
  • Method for assaying lower respiratory tract infection or inflammation
    Patent number: 11402390
    Abstract: The present invention relates to a reliable method of prediction of lower respiratory tract infection or inflammation in humans, wherein the level of pancreatic stone protein/regenerating protein (PSP/reg) is determined in serum, and a high level is indicative of the development and the severity of the disease, allowing the classification of patients according to risk.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: August 2, 2022
    Assignees: UNIVERSITY HOSPITAL OF BASEL, Lascco SA
    Inventors: Daiana Stolz, Frederic Lajaunias
  • IFN-GAMMA INHIBITORS IN THE TREATMENT OF MOTONEURON DISEASES
    Publication number: 20120276114
    Abstract: The present invention is directed to new compositions uses thereof and related methods for the treatment of a motoneuron disease or disorder. In particular, the invention relates to the new use of IFN? antagonists or viral vectors, uses, compositions thereof and related methods for the treatment of motoneuron disease or disorder such as ALS.
    Type: Application
    Filed: November 18, 2010
    Publication date: November 1, 2012
    Applicants: UNIVERSITE D'AIX-MARSEILLE, LASCCO SA
    Inventors: Samareh Azeredo Da Silveira Lajaunias, Julianne Aebischer, Cedric Raoul